Tirzepatide Sleep Apnea and Insomnia: A Night-by-Night Guide to What to Log

Why sleep can change on tirzepatide

If your sleep feels different since you started tirzepatide, you're not imagining it. Tirzepatide sleep changes can come from several directions at once. Weight loss itself can shift how your airway behaves at night. Nausea, reflux, or early fullness can wake you up. Appetite changes can alter when and what you eat in the evening. Many people also change their routines during treatment, and those changes affect sleep too. Sorting out which factor is driving things is the first step.

Excess weight, especially around the neck and upper airway, is linked to obstructive sleep apnea (OSA), a condition in which the airway repeatedly narrows or collapses during sleep. Because weight reduction can change that anatomy, researchers have studied whether losing weight with medication might help. The SURMOUNT-OSA trial, published in the New England Journal of Medicine in 2024 by Malhotra and colleagues, tested tirzepatide in adults with obesity and moderate-to-severe OSA. Its primary endpoint was the change in apnea-hypopnea index (AHI), a count of breathing events per hour of sleep, at week 52. Tirzepatide lowered AHI more than placebo in that trial. This does not promise a cure for apnea or insomnia. Trial results describe groups of people, and your own response may look different.

Sleep apnea: screening before and during treatment

A short questionnaire is a practical place to start. The STOP-BANG tool, validated by Chung and colleagues in Anesthesiology in 2008, asks eight yes or no questions. They cover Snoring, Tiredness during the day, Observed breathing pauses, high blood Pressure, BMI above 35, Age over 50, Neck circumference over 40 cm, and male Gender. Each yes earns one point, so the total runs from 0 to 8. A higher score signals higher risk of OSA, but only a sleep test can confirm it.

Two main tests confirm the diagnosis. In-lab polysomnography records breathing, oxygen levels, brain activity, and movement overnight at a sleep center. It is generally preferred when there are complicating factors, such as significant heart or lung disease or suspected other sleep disorders. Home sleep apnea testing uses a portable device in your own bed and is generally appropriate for adults with a high likelihood of uncomplicated OSA, according to American Academy of Sleep Medicine guidance. Your clinician decides which test fits your situation.

In December 2024, the US Food and Drug Administration approved tirzepatide, sold as Zepbound for weight management, for moderate-to-severe OSA in adults with obesity. Labeling differs by country, so if you live in Europe, check the current European Medicines Agency product information and ask your prescriber what your local label says.

If you already use CPAP, keep using it until your prescriber and sleep specialist tell you otherwise. Stopping on your own can bring symptoms back, and weight changes can affect mask fit and the pressure you need. Plan re-testing with your team as your weight changes. For a broader look at how CPAP follow-up fits alongside medication, read the TirzeBlog guide on apnea.

Insomnia and disrupted sleep: separating patterns from guesses

Trouble sleeping is not always insomnia. True insomnia means difficulty falling asleep or staying asleep at least a few nights a week, for months. A rough stretch after a dose change is a different story, and it often settles as your body adjusts. A written record helps you tell these apart instead of guessing.

Digestive symptoms are a common reason sleep breaks up. The prescribing information for tirzepatide lists nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia among its common adverse reactions. Heartburn can wake people in the small hours, and feeling full quickly can make a late dinner uncomfortable at bedtime.

When insomnia persists, cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment in major guidelines. The American Academy of Sleep Medicine's 2021 guideline recommends CBT-I for chronic insomnia, and the American College of Physicians named it first-line in its 2016 guideline. Many people find that CBT-I helps without medication, and it can be delivered in person or online.

Some contributors sit within your control. Caffeine late in the afternoon, alcohol near bedtime, stress, and screens in bed can all disturb sleep. Reviewing these habits yourself and noting them in your log gives your clinician useful context.

Injection timing, dose escalation, and nighttime symptoms

Many people notice more GI symptoms in the days after a dose increase. Your prescriber sets the escalation schedule, and stepping up gradually gives your body time to adjust. If nights get rough after a step, tell your team rather than changing anything on your own.

Several habits come up often in conversations with doctors. Smaller evening meals can ease fullness and reflux at bedtime. Spreading fluids through the day, instead of drinking a large glass right before lying down, may reduce nighttime discomfort. If reflux keeps interrupting sleep, some people raise the head of the bed. These are ideas to raise at your appointment, not instructions to follow without guidance.

Injection day and the time of day you inject are worth discussing with the care team too. Responses vary, and no single schedule fits everyone. Note your injection day and usual timing in your log so your team can spot patterns across dose steps.

Building a two-week sleep log to bring to your appointment

A simple diary beats memory. For two weeks, record your bedtime, how long it takes to fall asleep, how many times you wake, whether a partner has noticed snoring or breathing pauses, morning headaches, and daytime sleepiness on a 0 to 10 scale. Add your dose day as well, so symptoms line up with your injection schedule.

Wearables can add context, but they have limits. Consumer devices estimate sleep stages from movement and heart rate. The American Academy of Sleep Medicine has stated that consumer sleep technology is not intended to diagnose sleep disorders such as apnea, so treat device numbers as conversation starters. A log you can share makes that conversation far easier for the care team, and at TirzeBlog, our sleep-tracking resources can help you set one up.

Bring these three things to your visit:

• Your two-week sleep log, with dose days marked
• Your completed STOP-BANG score
• Your current medication list and any prior sleep study results

Red flags that need a call to your doctor this week

Most sleep changes can be handled through a regular conversation, but some signs call for prompt attention. Contact your doctor the same week if you notice drowsiness while driving, breathing pauses that a partner witnesses, persistent vomiting, signs of dehydration such as dizziness or very dark urine, or severe abdominal pain. Persistent or severe symptoms warrant a prompt visit rather than waiting for the next scheduled appointment.

If you have new mood changes or thoughts of harming yourself, contact your doctor right away. If those thoughts feel urgent, contact emergency services or a crisis line in your country now.

Chest pain or palpitations at night, fainting, or severe difficulty breathing need emergency care, not a scheduled visit. Call your local emergency number straight away.

What the evidence does and does not yet show

Some points are well established. In the SURMOUNT-OSA trial, tirzepatide lowered AHI more than placebo over 52 weeks, and the trial's weight loss ran alongside those changes. The product labeling documents GI side effects. Other questions remain open. Long-term effects of tirzepatide on insomnia, sleep architecture, and cardiovascular outcomes during sleep are not yet well characterized. Trials also enroll selected participants under controlled conditions, so everyday patients with different health histories may not see the same results.

Use these tools together. The sleep log shows patterns, the STOP-BANG score and a sleep test clarify whether apnea is present, and your prescriber and sleep specialist decide what comes next. Share the log at every visit, and bring questions about CPAP, dose timing, and insomnia to the same discussion. Good coordination keeps everyone working from the same information, and the TirzeBlog team's care-coordination notes offer a helpful way to organize who handles what.

FAQ

Does tirzepatide cause insomnia?

The main effects listed in the prescribing information are gastrointestinal, so disrupted sleep is often linked to nausea, reflux, fullness, or other changes during treatment. If trouble sleeping lasts for months, talk with your prescriber so other causes can be checked.

Can tirzepatide treat sleep apnea?

In the SURMOUNT-OSA trial, tirzepatide lowered AHI more than placebo in adults with obesity and moderate-to-severe OSA, and the FDA approved it for that indication in December 2024. It is not a cure, and decisions about CPAP stay with your clinician.

Should I stop CPAP when I start tirzepatide?

No, not on your own. Your prescriber and sleep specialist should guide any change, and they can re-test you as your weight changes.

Can a wearable tell me if I have sleep apnea?

No. Consumer devices are not designed to diagnose apnea. They can be useful for spotting trends, but a sleep test is needed to confirm or rule out the condition.

Sources

• Tirzepatide for Obstructive Sleep Apnea in Adults with Obesity (SURMOUNT-OSA), New England Journal of Medicine
• Chung F et al. STOP-Bang Questionnaire: A Practical Approach to Screen for Obstructive Sleep Apnea, Anesthesiology (2008)
• American Academy of Sleep Medicine, clinical resources and practice standards
• U.S. Food and Drug Administration, drug information and approvals
• U.S. FDA, Drugs@FDA prescribing information database
• European Medicines Agency, medicines and product information
• Edinger JD et al. Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults: AASM Clinical Practice Guideline, Journal of Clinical Sleep Medicine (2021)
• Qaseem A et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians, Annals of Internal Medicine (2016)
• Kolla BP et al. Consumer Sleep Technology: An American Academy of Sleep Medicine Position Statement, Journal of Clinical Sleep Medicine (2018)